Literature DB >> 8428219

Nitric oxide mediates the inhibition by interleukin-1 beta of pentagastrin-stimulated rat gastric acid secretion.

J V Esplugues1, M D Barrachina, S Calatayud, J M Pique, B J Whittle.   

Abstract

Bolus injection of interleukin-1 beta (2 micrograms kg-1, i.v.) inhibited acid secretion induced by intravenous infusion of pentagastrin (8 micrograms kg-1 h-1) in the continuously perfused stomach of the anaesthetized rat. Administration of interleukin-1 beta did not modify mean systemic arterial blood pressure. Pretreatment with NG-nitro-L-arginine methyl ester (L-NAME, 2-10 mg kg-1, i.v.), but not dexamethasone (5 mg kg-1, s.c. twice over 16 h), restored the acid secretory responses to pentagastrin. The actions of L-NAME were reversed by the prior administration of L-arginine (100 mg kg-1, i.v.), but not by its enantiomer D-arginine (100 mg kg-1, i.v.). L-NAME (5 mg kg-1, i.v.) increased blood pressure but this was not the mechanism by which interleukin-induced acid inhibition was prevented, since similar systemic pressor responses induced by phenylephrine (10 micrograms kg-1 min-1, i.v.), had no such effect. These findings suggest that interleukin-induced inhibition of acid responses to pentagastrin involves synthesis of NO from L-arginine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8428219      PMCID: PMC1907721          DOI: 10.1111/j.1476-5381.1993.tb13431.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  9 in total

1.  Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 2.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

3.  Endogenous nitric oxide as a mediator of gastric mucosal vasodilatation during acid secretion.

Authors:  J M Pique; J V Esplugues; B J Whittle
Journal:  Gastroenterology       Date:  1992-01       Impact factor: 22.682

4.  Interleukin-1 inhibits the secretion of gastric acid in rats: possible involvement of prostaglandin.

Authors:  A Uehara; T Okumura; C Sekiya; K Okamura; Y Takasugi; M Namiki
Journal:  Biochem Biophys Res Commun       Date:  1989-08-15       Impact factor: 3.575

5.  Secretagogue-specific effects of interleukin-1 on gastric acid secretion.

Authors:  J L Wallace; M Cucala; K Mugridge; L Parente
Journal:  Am J Physiol       Date:  1991-10

Review 6.  Interleukin-1.

Authors:  C A Dinarello
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

7.  Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat.

Authors:  I R Hutcheson; B J Whittle; N K Boughton-Smith
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

8.  Central action of recombinant interleukin-1 to inhibit acid secretion in rats.

Authors:  E S Saperas; H Yang; C Rivier; Y Taché
Journal:  Gastroenterology       Date:  1990-12       Impact factor: 22.682

9.  Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.

Authors:  D D Rees; R M Palmer; R Schulz; H F Hodson; S Moncada
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

  9 in total
  14 in total

1.  Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer.

Authors:  J Labenz; B Tillenburg; U Peitz; E Verdú; M Stolte; G Börsch; A L Blum
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

2.  Effect of Th1 cytokines on acid secretion in pharmacologically characterised mouse gastric glands.

Authors:  I T Padol; R H Hunt
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

3.  Nesfatin-1 inhibits gastric acid secretion via a central vagal mechanism in rats.

Authors:  Ze-Feng Xia; Danielle M Fritze; Ji-Yao Li; Biaoxin Chai; Chao Zhang; Weizhen Zhang; Michael W Mulholland
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-06-21       Impact factor: 4.052

Review 4.  Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor?

Authors:  J Labenz; P Malfertheiner
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

5.  Cytokine effects on pepsinogen secretion from human peptic cells.

Authors:  M T Serrano; A I Lanas; S Lorente; R Sáinz
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

6.  Effectiveness of acid suppression in preventing gastroesophageal reflux disease (GERD) after successful treatment of Helicobacter pylori infection.

Authors:  T Rokkas; S D Ladas; C Liatsos; E Panagou; A Karameris; S A Raptis
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

7.  Effects of inflammatory cytokines induced by Helicobacter pylori infection on aminopyrine accumulation in parietal cells isolated from guinea pigs.

Authors:  N Tani; Y Watanabe; T Suzuki; S Muramatsu; M Miyazawa; N Kimura; T Miwa
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

Review 8.  Thirteenth Gaddum Memorial Lecture. Neuronal and endothelium-derived mediators in the modulation of the gastric microcirculation: integrity in the balance.

Authors:  B J Whittle
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

Review 9.  Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms.

Authors:  Shingo Tsuji; Masahiko Tsujii; Hiroaki Murata; Tsutomu Nishida; Masato Komori; Masakazu Yasumaru; Shuji Ishii; Yoshiaki Sasayama; Sunao Kawano; Norio Hayashi
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

10.  Endotoxin inhibition of distension-stimulated gastric acid secretion in rat: mediation by NO in the central nervous system.

Authors:  M D Barrachina; B J Whittle; S Moncada; J V Esplugues
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.